Citius Oncology (CTOR) Inventory (2024 - 2026)

Citius Oncology (CTOR) has 3 years of Inventory data on file, last reported at $22.7 million in Q1 2026.

• On a quarterly basis, Inventory rose 47.72% year-over-year to $22.7 million in Q1 2026; TTM through Mar 2026 was $22.7 million, a 47.72% increase from a year earlier, with the FY2025 full-year figure at $22.3 million, up 169.53% from the prior year.
• Inventory for Q1 2026 stood at $22.7 million, roughly flat from $22.6 million in the prior quarter.
• Over the last five years, Inventory for CTOR reached as high as $22.7 million in Q1 2026 and fell as low as $8.3 million in Q3 2024.
• Historically, Inventory has averaged $17.5 million across 3 years, with a median of $17.2 million in 2025.
• Across the five-year window, Inventory soared 169.53% in 2025 and surged 47.72% in 2026, its largest moves.
• Year by year, Inventory stood at $14.4 million in 2024, then surged by 57.42% to $22.6 million in 2025, then increased by 0.09% to $22.7 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $22.7 million in Q1 2026, $22.6 million in Q4 2025, and $22.3 million in Q3 2025.